HTL is a biotechnology company, leading the way in the design, development and production of pharmaceutical grade hyaluronic acid (hyaluronan) and other functional biopolymers for premium medical products. HTL serves the pharmaceutical and medical device industries worldwide, enabling them to transform lives of patients.

With 25 years of proven experience, HTL is recognized for producing Hyaluronic Acid that features the highest quality standards for premium medical applications and meets every market need over the long term. Our approach to growth is to innovate in partnership with our clients and create value for the medical products of both today and tomorrow.  

HTL is developing new Glycosaminoglycans, i.e. Heparosan and Chondroitin, as well as functionalized Glycosaminoglycan derivatives (based on Hyaluronan, Heparosan or Chondroitin). HTL improves the functionalities of the end-products by controlling the physico-chemical characteristics, biological properties and durability of these biopolymers.

HTL conducts its production activities in fully compliant cGMP facilities. HTL organization is built on the principle of consistently understanding and meeting the specific needs of its customers from early development to market success, while providing expert support at every stage from R&D to Technical, Analytical and Regulatory, supporting its customers through the entire process.

Visit our website htlbiotech.com

Sales Markets

Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America

Meet us at

CPhI Worldwide 2021

Fiera Milano, Milan, Italy

31 August - 2 September 2021

Book a meeting
View Our Exhibitor Profile

Contact information

Address

Telephone

Website

View All Contact Info